BCL2 and breast cancer: Zhang et al57 observed that Bcl-2 gradually decreases during the development of breast cancer, i.e. from a normal epithelium (96%) to intraductal carcinoma (79%), and from intraductal to invasive carcinoma (45%), and reverse is observed in case of p53 expression.